Impact of an Automated Telephone Intervention on Glycosylated Hemoglobin (HbA1c) in Type 2 Diabetes
The Impact of an Automated Telephone Intervention on HbA1c in Type 2 Diabetes: A Randomized Controlled Trial
1 other identifier
interventional
120
1 country
1
Brief Summary
Aim 1. Determine the impact of a daily, automated telephone intervention on HbA1c levels compared to standard care in older patients with type 2 diabetes. Aim 2. Determine the impact of the automated telephone intervention compared to standard care on adherence to prescribed SMBG frequency in older patients with type 2 diabetes. Aim 3. Determine the impact of the automated telephone intervention compared to standard care on self-reported diabetic control problems in older patients with type 2 diabetes. Aim 4. Determine the impact of the automated telephone intervention compared to standard care on self-reported attitudes and health beliefs concerning diabetes in older patients with type 2 diabetes
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes
Started Jun 2007
Shorter than P25 for not_applicable type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
June 17, 2008
CompletedFirst Posted
Study publicly available on registry
June 19, 2008
CompletedFebruary 22, 2013
February 1, 2013
1 year
June 17, 2008
February 20, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in HbA1c
three months
Secondary Outcomes (1)
Change in adherence to SMBG frequency
three months
Study Arms (2)
1
EXPERIMENTALAutomated telephone intervention
2
ACTIVE COMPARATORUsual care
Interventions
Eligibility Criteria
You may qualify if:
- Age greater or equal to 55
- Type 2 diabetes
- English speaking
- Ability to use glucose meter
You may not qualify if:
- Unable to give informed consent
- Unwilling to allow SMBG levels to be shard with primary care physician
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Minnesotalead
- Novo Nordisk A/Scollaborator
Study Sites (1)
Primary Care Center University of Minnesota
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Judith Graziano, PhD, RN
University of Minnesota
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2008
First Posted
June 19, 2008
Study Start
June 1, 2007
Primary Completion
June 1, 2008
Study Completion
June 1, 2008
Last Updated
February 22, 2013
Record last verified: 2013-02